English  |  正體中文  |  简体中文  |  2815992  
???header.visitor??? :  27530847    ???header.onlineuser??? :  550
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"pritchard k i"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-05-25T06:52:03Z Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009 Pritchard K.I.;Shao Z.-M;Voravud N;Yen-Shen Lu;Yip C.H;Ang P.T;Khoo K.S;Anderson B.O;Wong N.S; Wong N.S; Anderson B.O; Khoo K.S; Ang P.T; Yip C.H; YEN-SHEN LU; Voravud N; Shao Z.-M; Pritchard K.I.
臺大學術典藏 2020-05-25T06:52:03Z Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009 Pritchard K.I.;Shao Z.-M;Voravud N;Yen-Shen Lu;Yip C.H;Ang P.T;Khoo K.S;Anderson B.O;Wong N.S; Wong N.S; Anderson B.O; Khoo K.S; Ang P.T; Yip C.H; YEN-SHEN LU; Voravud N; Shao Z.-M; Pritchard K.I.
臺大學術典藏 2016 Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial Piccart-Gebhart M.; Holmes E.; Baselga J.; De Azambuja E.; Dueck A.C.; Viale G.; Zujewski J.A.; Goldhirsch A.; Armour A.; Pritchard K.I.; McCullough A.E.; Dolci S.; McFadden E.; Holmes A.P.; Tonghua L.; Im Y.-H.; CHIUN-SHENG HUANG; D?eras V.; Hillman D.W.; Wolff A.C.; Jackisch C.; Lang I.; Untch M.; Smith I.; Boyle F.; Xu B.; Gomez H.; Suter T.; Gelber R.D.; Perez E.A.; Eidtmann H.; Dinh P.; Di Cosimo S.; Harbeck N.; Tjulandin S.

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page